Diseases /

Refractory Cytopenia with Multilineage Dysplasia and Ring Sideroblasts

Back to Diseases List

Overview

NCI Definition: A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia, dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines, and 15% or more ring sideroblasts in the bone marrow. (WHO, 2001) [1]

Clinical Trials

View Clinical Trials for Refractory Cytopenia with Multilineage Dysplasia and Ring Sideroblasts

Disease Details

Synonyms
MDS-RS-MLD, Refractory Cytopenia with Multilineage Dysplasia and Ringed Sideroblasts, MDS with Ring Sideroblasts and Multilineage Dysplasia, Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia, RCMD-RS
Parent(s)
Refractory anemia with ring sideroblasts
OncoTree Name
MDS with Ring Sideroblasts and Multilineage Dysplasia
OncoTree Code
MDSRSMD

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.